Patents by Inventor Shuren Zhu

Shuren Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8859578
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Grant
    Filed: October 5, 2012
    Date of Patent: October 14, 2014
    Assignee: Radix Pharmaceuticals, Inc.
    Inventor: Shuren Zhu
  • Publication number: 20140100240
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Application
    Filed: October 5, 2012
    Publication date: April 10, 2014
    Inventor: Shuren Zhu
  • Patent number: 8653095
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: February 18, 2014
    Assignee: Radix Pharmaceuticals, Inc.
    Inventor: Shuren Zhu
  • Publication number: 20130023552
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Application
    Filed: July 18, 2011
    Publication date: January 24, 2013
    Inventor: Shuren Zhu
  • Patent number: 8022080
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: September 20, 2011
    Assignee: Radix Pharmaceuticals Inc.
    Inventor: Shuren Zhu
  • Patent number: 7851508
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Grant
    Filed: October 8, 2008
    Date of Patent: December 14, 2010
    Assignee: Radix Pharmaceuticals, Inc.
    Inventor: Shuren Zhu
  • Publication number: 20100292264
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Application
    Filed: May 13, 2009
    Publication date: November 18, 2010
    Inventor: Shuren Zhu
  • Publication number: 20100087469
    Abstract: The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
    Type: Application
    Filed: October 8, 2008
    Publication date: April 8, 2010
    Inventor: Shuren Zhu
  • Publication number: 20080188498
    Abstract: The present invention provides pyridopyrimidinone compounds with desirable biological activity and toxicity profiles for the enhanced treatment and prevention of malaria. The invention also relates to methods of making such molecules.
    Type: Application
    Filed: February 5, 2007
    Publication date: August 7, 2008
    Inventor: Shuren Zhu
  • Patent number: 7314956
    Abstract: The present invention provides a drug delivery vehicle that can improve the pharmacokinetics of pharmacological agents. The invention relates to a multifunctional carrier capable of delivering a carried material such as a pharmacological agent or genetic material to a recipient. The multifunctional carrier includes a multifunctional core and a plurality of adduct molecules bonded thereto. The molecular carrier has surface functional groups which can be associated with a carried material. The carried material can be associated with the molecular carrier through covalent interactions or ionic interactions. The polyvalent core can be ethylene-diamine tetraacetic acid (EDTA) or succinic acid. The invention also relates to methods for producing and using such molecules.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: January 1, 2008
    Assignee: Vaxim, Inc.
    Inventors: Frank Q. Li, Yong Liang Chu, Shuren Zhu, Jian-Tai Qiu, Wan-Ching Lai
  • Publication number: 20030068379
    Abstract: The present invention provides a drug delivery vehicle that can improve the pharmacokinetics of pharmacological agents. The invention relates to a multifunctional carrier capable of delivering a carried material such as a pharmacological agent or genetic material to a recipient. The multifunctional carrier includes a multifunctional core and a plurality of adduct molecules bonded thereto. The molecular carrier has surface functional groups which can be associated with a carried material. The carried material can be associated with the molecular carrier through covalent interactions or ionic interactions. The polyvalent core can be ethylene-diamine tetraacetic acid (EDTA) or succinic acid. The invention also relates to methods for producing and using such molecules.
    Type: Application
    Filed: May 3, 2002
    Publication date: April 10, 2003
    Inventors: Frank Q. Li, Yong Liang Chu, Shuren Zhu, Jian-Tai Qiu, Wan-Ching Lai